Related Experiment Video
Updated: Jul 5, 2025
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease
1Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
Insights
Ischemic heart disease remains a global health crisis. Understanding myocardial ischemia/reperfusion is crucial for developing new treatments to combat rising mortality worldwide.
Area of Science:
- Cardiovascular Research
- Pathophysiology
- Translational Medicine
Background:
- Ischemic heart disease is the leading cause of global mortality.
- Myocardial ischemia/reperfusion injury underlies this condition.
- Despite advances, progress in treatment has plateaued, with increasing burden in developing nations.
Purpose of the Study:
- To review the current state of myocardial ischemia/reperfusion research.
- To examine both coronary vascular and myocardial aspects of the injury.
- To identify key areas for future research to improve clinical practice.
Main Methods:
- Comprehensive literature review of myocardial ischemia/reperfusion.
- Analysis of coronary vascular and myocardial injury mechanisms.
- Identification of knowledge gaps for clinical translation.
Main Results:
- Current understanding of ischemia/reperfusion is summarized.
- Key research frontiers in vascular and myocardial injury are highlighted.
- Areas requiring further mechanistic insight for clinical application are defined.
Conclusions:
- Further research into myocardial ischemia/reperfusion pathophysiology is essential.
- Addressing knowledge gaps will facilitate the development of novel therapeutic strategies.
- Improved understanding is critical for reducing the global burden of ischemic heart disease.
Abstract:
Ischemic heart disease is the greatest health burden and most frequent cause of death worldwide. Myocardial ischemia/reperfusion is the pathophysiological substrate of ischemic heart disease. Improvements in prevention and treatment of ischemic heart disease have reduced mortality in developed countries over the last decades, but further progress is now stagnant, and morbidity and mortality from ischemic heart disease in developing countries are increasing. Significant problems remain to be resolved and require a better pathophysiological understanding. The present review attempts to briefly summarize the state of the art in myocardial ischemia/reperfusion research, with a view on both its coronary vascular and myocardial aspects, and to define the cutting edges where further mechanistic knowledge is needed to facilitate translation to clinical practice.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:17Pathophysiology of Heart Failure